SlideShare uma empresa Scribd logo
1 de 46
Baixar para ler offline
Prof. Shaikh Abusufiyan
Assistant Professor,
AIKTC-School of Pharmacy,
New Panvel-410206
Factors affecting drug
absorption, Bioavailability and
Bioequivalence
Pharma Learning Forever
At the end of this e-learning session you are able to…
A. Explain factor affecting drug
absorption and bioavailability
and bioequivalence.
Factors affecting absorption
1. Aqueous solubility: Drugs given in solid form must dissolve in the
aqueous biophase before they are absorbed.
• Poorly water soluble drugs (aspirin, griseofulvin) rate of dissolution
governs rate of absorption.
• A drug given as watery solution: is absorbed faster than when the
same is given in solid form or as oily solution.
2. Concentration: Passive diffusion depends on
concentration gradient
• Drug given as concentrated solution
absorbed faster than from dilute solution.
3. Area of absorbing surface:
• Larger is the area
faster is the absorption.
3. Route of administration:
affects drug absorption, because each route
has its own peculiarities.
Oral
• The effective barrier to orally administered drugs is --> the
epithelial lining of the git- which is lipoidal.
• Nonionized lipid soluble drugs e.g. ethanol are readily absorbed
from stomach as well as intestine --> at rates proportional to
their lipid : water partition coefficient.
• Acidic drugs e.g. salicylates, barbifurates, etc. are
predominantly unionized in the acid gastric juice -->
absorbed from stomach
• While basic drugs e.g. morphine, quinine etc. are largely
ionized ---> absorbed only on reaching the duodenum.
• However, even for acidic drugs absorption from
stomach is slower- because
• Mucosa is thick
• Covered with mucus
• And the surface area is small.
• Absorbing surface area is much larger in the small
intestine due to villi.
Thus absorption of basic drug is faster as it is absorb
in intestine.
• Gastric emptying- Faster gastric emptying
--> accelerates drug absorption.
Particle size of drug and presence of food
• Particle size of the drug in solid dosage form governs rate of dissolution and in
turn rate of absorption.
• Presence of food dilutes the drug
Retards absorption.
• Further, certain drugs form poorly absorbed complexes with food constituents,
e.g. tetracyclines with calcium present in milk
• Thus most drugs are absorbed better if taken in empty
stomach.
• Highly ionized drugs e.g. Gentamicin, neostigmine
poorly absorbed when given orally.
GIT degradation of drug
• Certain drugs are degraded in the GIT --> ineffective orally
e.g.
• penicillin G by acid
• insulin by peptidases
Pharmaceutical dosage forms to overcome GI degradation
• Enteric coated tablets - having acid resistant coating
• Sustained release preparations coated with slowly dissolving materials
Influence of Efflux transporter P-gp
• The oral absorption of certain drug is low because a fraction of
the absorbed drug is excreted back into the intestinal lumen
by the efflux transporter P-gp .
• Eg. The low oral bioavailability of digoxin and cyclosporine is partly
accounted by above mechanism.
• Inhibitors of P-gp like quinidine/ verapamil erythromycin etc.
--> enhance bioavailability
• While P-gp inducer like rifampin and phenobarbitone -->
reduce the bioavailability of these drugs.
Q&A
Q.1 Why absorption of drugs from stomach is
slow?
Q.2 What is impact of food on drug
absorption?
Q.3 How Efflux transporter P-gp influence drug
absorption?
Copyright @shaikhabusufiyan2021
Activity II: Self learning
Concurrent ingested drugs
• Absorption of a drug can be affected by other concurrently
ingested drugs.
• May be a luminal effect
formation of insoluble complexes.
Eg tetracyclines with iron preparations, antacids, phenytoin with
sucralfate.
• Such interaction can be minimized by administering the two drugs
at 2-3 hr intervals.
Alteration of gut flora and gut wall effect
• Alteration of gut flora by antibiotics
May disrupt the enterohepatic cycling of oral contraceptives
and digoxin.
• Gut waII effects:
altering motility (Eg. anticholinergics, tricyclic
antidepressants, Metachlorpromide)
• causing mucosal damage (neomycin, methotrexate,
vinblastine).
Subcutaneous and Intramuscular route
• By these routes the drug is deposited directly in
the vicinity of the capillaries.
• Lipid soluble drugs pass readily across the whole
surface of the capillary endothelium.
• Large lipid insoluble molecules or ions
Capillaries (large paracellular spaces)
absorption
Speed of absorption:
• s.c site is slower than that from i.m. site
• But both are generally faster and more
consistent predictable than oral absorption.
Speed of absorption
• Application of heat and muscular exercise
Increases blood flow
Accelerate drug absorption
• Vasoconstrictors e.g. adrenaline
Retard absorption.
• Incorporation of hyaluronidase
catalyzes the hydrolysis of hyaluronan (a constituent
of the extracellular matrix ECM)
increases tissue permeability
promote spread of drug
Facilitates drug absorption from s.c. injection
• Eg of drugs given by s.c and i.m routs are:
• benzathine penicillin
• protamine zinc insulin
• depot progestins etc.
Topical application and drug absorption
• Topical sites : skin, cornea, mucous membranes
• Systemic absorption after topical application
Depends primarily on lipid solubility of drugs.
• However, only few drugs significantly penetrate
intact skin.
• Eg. Hyoscine, fentanyl, GTN, nicotine, testosterone,
and estradiol ect.
• Corticosteroids applied over extensive areas
produce systemic effects
Pituitary-adrenal suppression.
• Absorption by topical application can be promoted by
• by rubbing
• by incorporating drug in an olegenous base
• or by use of occlusive dressing which increases hydration of the
skin.
• Organophosphate insecticides coming in contact with skin
can produce systemic toxicity.
• Abraded surfaces readily absorb drugs e.g. tannic acid
applied over burn skin can produce hepatic necrosis
• Cornea is permeable to lipid soluble, unionized
physostigmine but not to highly ionized neostigmine.
• Drugs applied as eye drops
absorbed through the nasolacrimal duct
• E.g. Timolol eye drops may produce bradycardia and
precipitate asthma.
• Mucous membranes of mouth, rectum, vagina
absorb lipophilic drugs
• Eg. Estrogen cream applied vaginally has produced
gynaecomastia in the male partner.
Q&A
Q.1 Explain luminal effect with
example? How to overcome it?
Q.2 What is the effect of heat and
vasoconstrictors on drug absorption.
Q.3 How absorption by topical
applications can be promoted ?
Copyright @shaikhabusufiyan2021
BIOAVAILABILITY
• The rate and extent of absorption of a drug from a dosage form -->is
called as bioavailability.
• It is determined by
• its concentration-time curve in blood
• its excretion in urine.
• It is a measure of the fraction (F) of --> administered dose of a drug
that reaches the systemic circulation in the unchanged form.
• Bioavailability of drug injected i.v. --> 100%
• But is frequently lower --> after oral ingestion
because:-
(a) the drug may be --> incompletely absorbed.
(b) the absorbed drug --> may undergo first pass
metabolism in the intestinal wall/ liver or excreted in bile.
• Incomplete bioavailability after s.c. or i.m.
Injection is less common
May occur due to local binding of the drug.
Biologically inequivalent
• Oral formulations of a drug from different
manufacturers
• or different batches from the same manufacturer
may have the same amount of the drug (chemically
equivalent)
• but may not yield the same blood levels-
biologically inequivalent.
Bioequivalent
• Two preparations of a drug are considered bioequivalent when
the rate and extent of bioavailability of the drug from two
formulations is not significantly different under suitable test
conditions.
• Bioavailability is depend on two important process:
1. Disintegration
2. Dissolution
• Factor affecting disintegration are nature of
• diluents
• stabilizing agents
• binders
• lubricants
• compression force used for tablets etc.
• The rate of dissolution is governed by the
• inherent solubility
• particle size
• crystal form
• And other physical properties of the drug.
• Differences in bioavailability may arise --> due to variations in
disintegration and dissolution rates.
• And seen mostly with --> poorly soluble and slowly absorbed
drugs.
Particle size
• Eg. Reduction in particle size --> increases the rate of
absorption of aspirin (microfine tablets).
• The dose of griseofulvin and spironolactone in the tablet -->
can be reduced to half if the drug particle is microfine.
• There is no need to reduce the particle size --> freely water
soluble drugs e.g. paracetamol.
Cases where bioavailability is important
Bioavailability variation is important in case of:
1. Drugs with --> low safety margin (digoxin)
2. Or where dosage --> needs precise control (oral
hypoglycaemics, oral anticoagulants).
3. Success or failure --> of an antimicrobial regimen.
Q&A
Q.1 Define bioavailability and bioequivalent.
Q.2 Enlist Factor affecting disintegration.
Q.3 In which case bioavailability is important?
Copyright @shaikhabusufiyan2021
Reference:
• K D Tripathi. Essentials of Medical
Pharmacology. Seventh Edition. Jaypee
Publication. Page no:15-18.
Disclaimer (Images)
• The images used in this presentation are found from different sources all over
the Internet, and are assumed to be in public domain and are displayed under the
fair use principle for education purpose.
Copyright @ Presentation
• The said presentation is copyright under Copyright @shaikhabusufiyan2022
• The presentation is for education purpose only, don’t use the same for any legal
perspective.
Absorption, Bioavailability and Bioequivalance.pdf

Mais conteúdo relacionado

Semelhante a Absorption, Bioavailability and Bioequivalance.pdf

Bioavailability and bioequivalence
Bioavailability and bioequivalenceBioavailability and bioequivalence
Bioavailability and bioequivalenceDr. Fehmi Mukadam
 
Biopharm facors affecting drug bioavailability
Biopharm facors affecting drug bioavailabilityBiopharm facors affecting drug bioavailability
Biopharm facors affecting drug bioavailabilitychiranjibi68
 
Dosage form design - Biopharmaceutical consideration
Dosage form design - Biopharmaceutical considerationDosage form design - Biopharmaceutical consideration
Dosage form design - Biopharmaceutical considerationAniruddha Roy
 
General Pharmacology part 02.pptx
General Pharmacology part 02.pptxGeneral Pharmacology part 02.pptx
General Pharmacology part 02.pptxMAYUR HARAL
 
General pharmacology Diploma in pharmacy second year
General pharmacology Diploma in pharmacy second year General pharmacology Diploma in pharmacy second year
General pharmacology Diploma in pharmacy second year YogeshShelake
 
Introduction to biopharmaceutics (part:04)
Introduction to biopharmaceutics (part:04)Introduction to biopharmaceutics (part:04)
Introduction to biopharmaceutics (part:04)MdNazmulIslamTanmoy
 
PHARMACOKINETIC
PHARMACOKINETICPHARMACOKINETIC
PHARMACOKINETICSanjogBam
 
Introduction to pharmacology Part 2 ppt.pptx
Introduction to pharmacology Part 2 ppt.pptxIntroduction to pharmacology Part 2 ppt.pptx
Introduction to pharmacology Part 2 ppt.pptxImranUllah81
 
pharmacokinetics- a detailed and easy way to learn
pharmacokinetics- a detailed and easy way to learnpharmacokinetics- a detailed and easy way to learn
pharmacokinetics- a detailed and easy way to learnKarthikrajaS6
 
Pharmacokinetics class 2
Pharmacokinetics   class 2Pharmacokinetics   class 2
Pharmacokinetics class 2candyshridhar24
 
Physiological factors effecting bioavailability{ndds.2(1)}
Physiological factors effecting bioavailability{ndds.2(1)}Physiological factors effecting bioavailability{ndds.2(1)}
Physiological factors effecting bioavailability{ndds.2(1)}Nandhini Podamekala
 
Sustain release drug delievery system
Sustain release drug delievery systemSustain release drug delievery system
Sustain release drug delievery systemPratikShinde120
 
Fundamentals of LA Administration
Fundamentals of LA AdministrationFundamentals of LA Administration
Fundamentals of LA Administrationletsgogaga
 

Semelhante a Absorption, Bioavailability and Bioequivalance.pdf (20)

Bioavailability and bioequivalence
Bioavailability and bioequivalenceBioavailability and bioequivalence
Bioavailability and bioequivalence
 
1 Pharmacology Pharmacokinetics
1 Pharmacology   Pharmacokinetics1 Pharmacology   Pharmacokinetics
1 Pharmacology Pharmacokinetics
 
Biopharm facors affecting drug bioavailability
Biopharm facors affecting drug bioavailabilityBiopharm facors affecting drug bioavailability
Biopharm facors affecting drug bioavailability
 
Dosage form design - Biopharmaceutical consideration
Dosage form design - Biopharmaceutical considerationDosage form design - Biopharmaceutical consideration
Dosage form design - Biopharmaceutical consideration
 
General Pharmacology part 02.pptx
General Pharmacology part 02.pptxGeneral Pharmacology part 02.pptx
General Pharmacology part 02.pptx
 
Pharmacology part 2
Pharmacology part 2Pharmacology part 2
Pharmacology part 2
 
PHARMACOKINETICS.pptx
PHARMACOKINETICS.pptxPHARMACOKINETICS.pptx
PHARMACOKINETICS.pptx
 
General pharmacology Diploma in pharmacy second year
General pharmacology Diploma in pharmacy second year General pharmacology Diploma in pharmacy second year
General pharmacology Diploma in pharmacy second year
 
Introduction to biopharmaceutics (part:04)
Introduction to biopharmaceutics (part:04)Introduction to biopharmaceutics (part:04)
Introduction to biopharmaceutics (part:04)
 
PHARMACOKINETIC
PHARMACOKINETICPHARMACOKINETIC
PHARMACOKINETIC
 
Introduction to pharmacology Part 2 ppt.pptx
Introduction to pharmacology Part 2 ppt.pptxIntroduction to pharmacology Part 2 ppt.pptx
Introduction to pharmacology Part 2 ppt.pptx
 
pharmacokinetics- a detailed and easy way to learn
pharmacokinetics- a detailed and easy way to learnpharmacokinetics- a detailed and easy way to learn
pharmacokinetics- a detailed and easy way to learn
 
PKPD NEW.pptx
PKPD NEW.pptxPKPD NEW.pptx
PKPD NEW.pptx
 
PHARMA-PHARMACOKINETICS
PHARMA-PHARMACOKINETICSPHARMA-PHARMACOKINETICS
PHARMA-PHARMACOKINETICS
 
Pharmacokinetics class 2
Pharmacokinetics   class 2Pharmacokinetics   class 2
Pharmacokinetics class 2
 
Physiological factors effecting bioavailability{ndds.2(1)}
Physiological factors effecting bioavailability{ndds.2(1)}Physiological factors effecting bioavailability{ndds.2(1)}
Physiological factors effecting bioavailability{ndds.2(1)}
 
Pharmacokinetics.pptx
Pharmacokinetics.pptxPharmacokinetics.pptx
Pharmacokinetics.pptx
 
Pharmacokinetics,
Pharmacokinetics, Pharmacokinetics,
Pharmacokinetics,
 
Sustain release drug delievery system
Sustain release drug delievery systemSustain release drug delievery system
Sustain release drug delievery system
 
Fundamentals of LA Administration
Fundamentals of LA AdministrationFundamentals of LA Administration
Fundamentals of LA Administration
 

Mais de Shaikh Abusufyan

PHARMACOKINETIC- ABSORPTION, DISTRIBUTION (1) [Autosaved].pptx
PHARMACOKINETIC- ABSORPTION, DISTRIBUTION  (1) [Autosaved].pptxPHARMACOKINETIC- ABSORPTION, DISTRIBUTION  (1) [Autosaved].pptx
PHARMACOKINETIC- ABSORPTION, DISTRIBUTION (1) [Autosaved].pptxShaikh Abusufyan
 
antiprotozoal_Antimalarial_drugs.pdf
antiprotozoal_Antimalarial_drugs.pdfantiprotozoal_Antimalarial_drugs.pdf
antiprotozoal_Antimalarial_drugs.pdfShaikh Abusufyan
 
Neurohumoral Transmission.pdf
Neurohumoral Transmission.pdfNeurohumoral Transmission.pdf
Neurohumoral Transmission.pdfShaikh Abusufyan
 
Agonists and Antagonist.pdf
Agonists and Antagonist.pdfAgonists and Antagonist.pdf
Agonists and Antagonist.pdfShaikh Abusufyan
 
Chemotherapy_Chloramphenicol.pdf
Chemotherapy_Chloramphenicol.pdfChemotherapy_Chloramphenicol.pdf
Chemotherapy_Chloramphenicol.pdfShaikh Abusufyan
 
CHEMOTHERAPY_Cephalosporin.pdf
CHEMOTHERAPY_Cephalosporin.pdfCHEMOTHERAPY_Cephalosporin.pdf
CHEMOTHERAPY_Cephalosporin.pdfShaikh Abusufyan
 
Routs of drug administration.pptx
Routs of drug administration.pptxRouts of drug administration.pptx
Routs of drug administration.pptxShaikh Abusufyan
 
Introduction to Pharmacol.pdf
Introduction to Pharmacol.pdfIntroduction to Pharmacol.pdf
Introduction to Pharmacol.pdfShaikh Abusufyan
 
Nasal decongestants and Respiratory Stimulants.pdf
Nasal decongestants and Respiratory Stimulants.pdfNasal decongestants and Respiratory Stimulants.pdf
Nasal decongestants and Respiratory Stimulants.pdfShaikh Abusufyan
 
Antibiotics: Penicillin.pdf
Antibiotics: Penicillin.pdfAntibiotics: Penicillin.pdf
Antibiotics: Penicillin.pdfShaikh Abusufyan
 
Adverse drug reactions.pdf
Adverse drug reactions.pdfAdverse drug reactions.pdf
Adverse drug reactions.pdfShaikh Abusufyan
 
Drug discovery and development
Drug discovery and developmentDrug discovery and development
Drug discovery and developmentShaikh Abusufyan
 

Mais de Shaikh Abusufyan (20)

PHARMACOKINETIC- ABSORPTION, DISTRIBUTION (1) [Autosaved].pptx
PHARMACOKINETIC- ABSORPTION, DISTRIBUTION  (1) [Autosaved].pptxPHARMACOKINETIC- ABSORPTION, DISTRIBUTION  (1) [Autosaved].pptx
PHARMACOKINETIC- ABSORPTION, DISTRIBUTION (1) [Autosaved].pptx
 
antiprotozoal_Antimalarial_drugs.pdf
antiprotozoal_Antimalarial_drugs.pdfantiprotozoal_Antimalarial_drugs.pdf
antiprotozoal_Antimalarial_drugs.pdf
 
Neurohumoral Transmission.pdf
Neurohumoral Transmission.pdfNeurohumoral Transmission.pdf
Neurohumoral Transmission.pdf
 
Drug Excretion.pdf
Drug Excretion.pdfDrug Excretion.pdf
Drug Excretion.pdf
 
Anthelmintics drugs.pdf
Anthelmintics drugs.pdfAnthelmintics drugs.pdf
Anthelmintics drugs.pdf
 
Drug metabolism.pdf
Drug metabolism.pdfDrug metabolism.pdf
Drug metabolism.pdf
 
Drug Distribution.pdf
Drug Distribution.pdfDrug Distribution.pdf
Drug Distribution.pdf
 
Anti-fungal drugs.pdf
Anti-fungal drugs.pdfAnti-fungal drugs.pdf
Anti-fungal drugs.pdf
 
Agonists and Antagonist.pdf
Agonists and Antagonist.pdfAgonists and Antagonist.pdf
Agonists and Antagonist.pdf
 
Macrolides.pdf
Macrolides.pdfMacrolides.pdf
Macrolides.pdf
 
Chemotherapy_Chloramphenicol.pdf
Chemotherapy_Chloramphenicol.pdfChemotherapy_Chloramphenicol.pdf
Chemotherapy_Chloramphenicol.pdf
 
CHEMOTHERAPY_Cephalosporin.pdf
CHEMOTHERAPY_Cephalosporin.pdfCHEMOTHERAPY_Cephalosporin.pdf
CHEMOTHERAPY_Cephalosporin.pdf
 
Routs of drug administration.pptx
Routs of drug administration.pptxRouts of drug administration.pptx
Routs of drug administration.pptx
 
Introduction to Pharmacol.pdf
Introduction to Pharmacol.pdfIntroduction to Pharmacol.pdf
Introduction to Pharmacol.pdf
 
Nasal decongestants and Respiratory Stimulants.pdf
Nasal decongestants and Respiratory Stimulants.pdfNasal decongestants and Respiratory Stimulants.pdf
Nasal decongestants and Respiratory Stimulants.pdf
 
Antibiotics: Penicillin.pdf
Antibiotics: Penicillin.pdfAntibiotics: Penicillin.pdf
Antibiotics: Penicillin.pdf
 
Adverse drug reactions.pdf
Adverse drug reactions.pdfAdverse drug reactions.pdf
Adverse drug reactions.pdf
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
Pharmacoepidemiology
 
Drug discovery and development
Drug discovery and developmentDrug discovery and development
Drug discovery and development
 

Último

Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondSujoy Dasgupta
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyMedicoseAcademics
 
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfSGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfHongBiThi1
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...Shubhanshu Gaurav
 
pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologyDeepakDaniel9
 
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdfSGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdfHongBiThi1
 
Unit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptUnit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptPradnya Wadekar
 
Mental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil ThirusanguMental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil Thirusangu Medical University
 
power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismusChandrasekar Reddy
 
MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.whalesdesign
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationMedicoseAcademics
 
Basic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxBasic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxkomalt2001
 
Red Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfRed Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfMedicoseAcademics
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024EwoutSteyerberg1
 
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptxORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptxNIKITA BHUTE
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfDolisha Warbi
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfHongBiThi1
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .Mohamed Rizk Khodair
 
AORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectionAORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectiondrhanifmohdali
 

Último (20)

Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and Beyond
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before Pregnancy
 
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfSGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
 
pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacology
 
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdfSGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
 
Unit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptUnit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.ppt
 
Mental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil ThirusanguMental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil Thirusangu
 
power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismus
 
MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
 
Basic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxBasic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptx
 
Red Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfRed Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdf
 
How to master Steroid (glucocorticoids) prescription, different scenarios, ca...
How to master Steroid (glucocorticoids) prescription, different scenarios, ca...How to master Steroid (glucocorticoids) prescription, different scenarios, ca...
How to master Steroid (glucocorticoids) prescription, different scenarios, ca...
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024
 
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptxORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .
 
AORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectionAORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissection
 

Absorption, Bioavailability and Bioequivalance.pdf

  • 1. Prof. Shaikh Abusufiyan Assistant Professor, AIKTC-School of Pharmacy, New Panvel-410206 Factors affecting drug absorption, Bioavailability and Bioequivalence Pharma Learning Forever
  • 2. At the end of this e-learning session you are able to… A. Explain factor affecting drug absorption and bioavailability and bioequivalence.
  • 3. Factors affecting absorption 1. Aqueous solubility: Drugs given in solid form must dissolve in the aqueous biophase before they are absorbed. • Poorly water soluble drugs (aspirin, griseofulvin) rate of dissolution governs rate of absorption. • A drug given as watery solution: is absorbed faster than when the same is given in solid form or as oily solution.
  • 4. 2. Concentration: Passive diffusion depends on concentration gradient • Drug given as concentrated solution absorbed faster than from dilute solution.
  • 5. 3. Area of absorbing surface: • Larger is the area faster is the absorption.
  • 6. 3. Route of administration: affects drug absorption, because each route has its own peculiarities.
  • 7. Oral • The effective barrier to orally administered drugs is --> the epithelial lining of the git- which is lipoidal. • Nonionized lipid soluble drugs e.g. ethanol are readily absorbed from stomach as well as intestine --> at rates proportional to their lipid : water partition coefficient.
  • 8. • Acidic drugs e.g. salicylates, barbifurates, etc. are predominantly unionized in the acid gastric juice --> absorbed from stomach • While basic drugs e.g. morphine, quinine etc. are largely ionized ---> absorbed only on reaching the duodenum.
  • 9. • However, even for acidic drugs absorption from stomach is slower- because • Mucosa is thick • Covered with mucus • And the surface area is small.
  • 10. • Absorbing surface area is much larger in the small intestine due to villi. Thus absorption of basic drug is faster as it is absorb in intestine. • Gastric emptying- Faster gastric emptying --> accelerates drug absorption.
  • 11. Particle size of drug and presence of food • Particle size of the drug in solid dosage form governs rate of dissolution and in turn rate of absorption. • Presence of food dilutes the drug Retards absorption. • Further, certain drugs form poorly absorbed complexes with food constituents, e.g. tetracyclines with calcium present in milk
  • 12. • Thus most drugs are absorbed better if taken in empty stomach. • Highly ionized drugs e.g. Gentamicin, neostigmine poorly absorbed when given orally.
  • 13. GIT degradation of drug • Certain drugs are degraded in the GIT --> ineffective orally e.g. • penicillin G by acid • insulin by peptidases Pharmaceutical dosage forms to overcome GI degradation • Enteric coated tablets - having acid resistant coating • Sustained release preparations coated with slowly dissolving materials
  • 14. Influence of Efflux transporter P-gp • The oral absorption of certain drug is low because a fraction of the absorbed drug is excreted back into the intestinal lumen by the efflux transporter P-gp . • Eg. The low oral bioavailability of digoxin and cyclosporine is partly accounted by above mechanism.
  • 15. • Inhibitors of P-gp like quinidine/ verapamil erythromycin etc. --> enhance bioavailability • While P-gp inducer like rifampin and phenobarbitone --> reduce the bioavailability of these drugs.
  • 16. Q&A Q.1 Why absorption of drugs from stomach is slow? Q.2 What is impact of food on drug absorption? Q.3 How Efflux transporter P-gp influence drug absorption? Copyright @shaikhabusufiyan2021
  • 17. Activity II: Self learning
  • 18. Concurrent ingested drugs • Absorption of a drug can be affected by other concurrently ingested drugs. • May be a luminal effect formation of insoluble complexes. Eg tetracyclines with iron preparations, antacids, phenytoin with sucralfate. • Such interaction can be minimized by administering the two drugs at 2-3 hr intervals.
  • 19. Alteration of gut flora and gut wall effect • Alteration of gut flora by antibiotics May disrupt the enterohepatic cycling of oral contraceptives and digoxin. • Gut waII effects: altering motility (Eg. anticholinergics, tricyclic antidepressants, Metachlorpromide) • causing mucosal damage (neomycin, methotrexate, vinblastine).
  • 20. Subcutaneous and Intramuscular route • By these routes the drug is deposited directly in the vicinity of the capillaries. • Lipid soluble drugs pass readily across the whole surface of the capillary endothelium. • Large lipid insoluble molecules or ions Capillaries (large paracellular spaces) absorption
  • 21. Speed of absorption: • s.c site is slower than that from i.m. site • But both are generally faster and more consistent predictable than oral absorption.
  • 22. Speed of absorption • Application of heat and muscular exercise Increases blood flow Accelerate drug absorption • Vasoconstrictors e.g. adrenaline Retard absorption.
  • 23. • Incorporation of hyaluronidase catalyzes the hydrolysis of hyaluronan (a constituent of the extracellular matrix ECM) increases tissue permeability promote spread of drug Facilitates drug absorption from s.c. injection
  • 24. • Eg of drugs given by s.c and i.m routs are: • benzathine penicillin • protamine zinc insulin • depot progestins etc.
  • 25. Topical application and drug absorption • Topical sites : skin, cornea, mucous membranes • Systemic absorption after topical application Depends primarily on lipid solubility of drugs.
  • 26. • However, only few drugs significantly penetrate intact skin. • Eg. Hyoscine, fentanyl, GTN, nicotine, testosterone, and estradiol ect. • Corticosteroids applied over extensive areas produce systemic effects Pituitary-adrenal suppression.
  • 27. • Absorption by topical application can be promoted by • by rubbing • by incorporating drug in an olegenous base • or by use of occlusive dressing which increases hydration of the skin.
  • 28. • Organophosphate insecticides coming in contact with skin can produce systemic toxicity. • Abraded surfaces readily absorb drugs e.g. tannic acid applied over burn skin can produce hepatic necrosis
  • 29. • Cornea is permeable to lipid soluble, unionized physostigmine but not to highly ionized neostigmine. • Drugs applied as eye drops absorbed through the nasolacrimal duct • E.g. Timolol eye drops may produce bradycardia and precipitate asthma.
  • 30. • Mucous membranes of mouth, rectum, vagina absorb lipophilic drugs • Eg. Estrogen cream applied vaginally has produced gynaecomastia in the male partner.
  • 31. Q&A Q.1 Explain luminal effect with example? How to overcome it? Q.2 What is the effect of heat and vasoconstrictors on drug absorption. Q.3 How absorption by topical applications can be promoted ? Copyright @shaikhabusufiyan2021
  • 32. BIOAVAILABILITY • The rate and extent of absorption of a drug from a dosage form -->is called as bioavailability. • It is determined by • its concentration-time curve in blood • its excretion in urine. • It is a measure of the fraction (F) of --> administered dose of a drug that reaches the systemic circulation in the unchanged form.
  • 33. • Bioavailability of drug injected i.v. --> 100% • But is frequently lower --> after oral ingestion because:- (a) the drug may be --> incompletely absorbed. (b) the absorbed drug --> may undergo first pass metabolism in the intestinal wall/ liver or excreted in bile.
  • 34. • Incomplete bioavailability after s.c. or i.m. Injection is less common May occur due to local binding of the drug.
  • 35. Biologically inequivalent • Oral formulations of a drug from different manufacturers • or different batches from the same manufacturer may have the same amount of the drug (chemically equivalent) • but may not yield the same blood levels- biologically inequivalent.
  • 36. Bioequivalent • Two preparations of a drug are considered bioequivalent when the rate and extent of bioavailability of the drug from two formulations is not significantly different under suitable test conditions.
  • 37. • Bioavailability is depend on two important process: 1. Disintegration 2. Dissolution
  • 38. • Factor affecting disintegration are nature of • diluents • stabilizing agents • binders • lubricants • compression force used for tablets etc.
  • 39. • The rate of dissolution is governed by the • inherent solubility • particle size • crystal form • And other physical properties of the drug.
  • 40. • Differences in bioavailability may arise --> due to variations in disintegration and dissolution rates. • And seen mostly with --> poorly soluble and slowly absorbed drugs. Particle size • Eg. Reduction in particle size --> increases the rate of absorption of aspirin (microfine tablets).
  • 41. • The dose of griseofulvin and spironolactone in the tablet --> can be reduced to half if the drug particle is microfine. • There is no need to reduce the particle size --> freely water soluble drugs e.g. paracetamol.
  • 42. Cases where bioavailability is important Bioavailability variation is important in case of: 1. Drugs with --> low safety margin (digoxin) 2. Or where dosage --> needs precise control (oral hypoglycaemics, oral anticoagulants). 3. Success or failure --> of an antimicrobial regimen.
  • 43. Q&A Q.1 Define bioavailability and bioequivalent. Q.2 Enlist Factor affecting disintegration. Q.3 In which case bioavailability is important? Copyright @shaikhabusufiyan2021
  • 44. Reference: • K D Tripathi. Essentials of Medical Pharmacology. Seventh Edition. Jaypee Publication. Page no:15-18.
  • 45. Disclaimer (Images) • The images used in this presentation are found from different sources all over the Internet, and are assumed to be in public domain and are displayed under the fair use principle for education purpose. Copyright @ Presentation • The said presentation is copyright under Copyright @shaikhabusufiyan2022 • The presentation is for education purpose only, don’t use the same for any legal perspective.